Skip to content
10-Q

Quarterly Report

PEAK PHARMACEUTICALS, INC. RMHI

0001199835-22-000816

← back to feed
Filed
Dec 19, 2022 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Cash And Equivalents Q1 2020 · Dec 31, 2019 $0
Stockholders Equity Q1 2020 · Dec 31, 2019 −$238.61K
Stockholders Equity Q1 2020 · Sep 30, 2019 −$235.09K
Current Liabilities Q1 2020 · Dec 31, 2019 $239.1K
Current Liabilities Q1 2020 · Sep 30, 2019 $235.61K
Total Liabilities Q1 2020 · Dec 31, 2019 $239.1K
Total Liabilities Q1 2020 · Sep 30, 2019 $235.61K
Current Assets Q1 2020 · Dec 31, 2019 $498
Current Assets Q1 2020 · Sep 30, 2019 $527
Total Assets Q1 2020 · Dec 31, 2019 $498
Total Assets Q1 2020 · Sep 30, 2019 $527
Net Income Q1 2020 · Dec 31, 2019 −$3.52K
Operating Cash Flow Q1 2020 · Dec 31, 2018 −$1.51K
Operating Income Q1 2020 · Dec 31, 2018 −$953